The FDA as we’ve known it is finished, with most of the leaders with institutional knowledge and a deep understanding of ...
Moderna (MRNA) is another interesting choice today. MRNA stock has dropped 11.66% alongside the FDA news, the largest of the ...
Vaccine stocks are down after the health agency's top immunization official announced the move Monday, citing Secretary ...
Shares of some U.S. biotechnology companies including Moderna (MRNA) plunged on Monday after reports that the top vaccine ...
Shares of Moderna, Novavax and other biotech companies fell after FDA official Peter Marks’s resignation in protest of Robert ...
As director of the FDA's Center for Biologics Evaluation and Research, Marks has publicly supported programs that expedited ...
By Manas Mishra (Reuters) -Shares of U.S. drugmakers fell before the bell on Monday after reports that the Food and Drug ...
The FDA highlighted two key Chemistry ... views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New York ...
Sanofi SNY announced that the FDA has accepted its regulatory filing seeking approval for its investigational BTK inhibitor tolebrutinib to treat non-relapsing secondary progressive multiple ...
Specifically, the FDA noted that changes to the sensor coating ... You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. Cardinal Health’s shares have gained 12.2 ...
Merck MRK announced that the FDA has accepted its regulatory filing ... Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming ...
The FDA approval of Soleno’s Vykat XR for the ... We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed ...